MétaCan
Menu
Back to cohort
Record W2987235359 · doi:10.1016/s0167-8140(19)33149-4

10 The Impact of Dose to Bladder Neck on Urinary Toxicity in Patients Treated with HDR Brachytherapy Boost for Prostate Cancer

2019· article· en· W2987235359 on OpenAlexaff
Ibtihel Ben Aicha, Damien Carignan, André‐Guy Martin, Philippe Després, William J. Foster, Marie‐Claude Lavallée, Sylviane Aubin, Luc Beaulieu, Frédéric Lacroix

Bibliographic record

VenueRadiotherapy and Oncology · 2019
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsUniversity of AlbertaUniversity of TorontoQueen's UniversityUniversity of British Columbia
Fundersnot available
KeywordsBrachytherapyMedicineProstate cancerUrologyNeck of urinary bladderProstateToxicityUrinary systemUrinary bladderCancerOncologyRadiation therapyRadiologyInternal medicine

Abstract

fetched live from OpenAlex

CARO-ASM 2019 radiotherapy (hypoRT) have shown promising outcomes.Large randomized trials comparing the modalities have yet to be completed.The objective of this study is to compare the provincial outcomes of patients treated with SBRT/hypoRT to those treated with surgery. Materials and Methods:We conducted a retrospective analysis of all provincial patients with Stage I NSCLC who underwent surgery or SBRT/hypoRT (biological equivalent dose of at least 84 Gy), from 2006 to 2016.Baseline patient, tumour, treatment and clinical outcome data were collected from the British Columbia Cancer Registry.Overall survival (OS) and cancer specific survival (CSS) were analyzed using Kaplan-Meier method.We further analyzed patients based on age, with 75 as cut off for older population.Cox regression analysis was performed to identify predictors of outcomes.Results: Among 1230 patients, 235 (19.1%) were treated with SBRT/hypoRT and 995 (80.9%) with surgery.158 (12.2%) patients received 48Gy in 4Fx, 42 (3.4%)60Gy in 8Fx, 35 (2.8%) 60Gy in 15Fx.783 (63.7%) patients underwent lobectomy, 28 (2.3%) pneumonectomy, 184 (15.0%) sub-lobar resection.The median age was 69, with 339 (27.6%) age >75.The median follow-up was 26.2 months for SBRT/hypoRT and 29.4 months for surgery.The two-and five-year OS were 73.8% and 27.7% for SBRT/hypoRT, and 78.4% and 36.1% for surgery, with no significant difference between the groups (p=0.182).Differences in OS were not significant among the radiotherapy dose fractionations (p=0.653) or the surgery types (p=0.193).Comparing SBRT/hypoRT to surgery, significant differences in OS were not detected for patients age <75 (p=0.299)nor >75 (p=0.224).The two-and five-year CSS were respectively 85.2% and 54.3% for SBRT/hypoRT, and 81.1% and 42.2% for surgery, with improved outcomes in the SBRT/hypoRT group (p=0.004).Patients age >75 had greater CSS with SBRT/ hypoRT (p<0.001), with no significant difference in patients age <75 (p=0.077).On multivariate analysis, there was no significant indicator of improved OS found for the SBRT/hypoRT group.For the surgery group, age <75 (p<0.001)predicted for better OS while ECOG (ref=0) 2 (p=0.041), 3 (p<0.001),4 (p<0.001)predicted for worse.Conclusions: At a registry level, SBRT/hypoRT achieves OS outcomes similar to surgery.Improved CSS is observed in the SBRT/ hypoRT cohort, notably for patients age >75.Further evaluation in large randomized studies is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.323
Teacher spread0.310 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractno

Explore more

Same venueRadiotherapy and OncologySame topicBladder and Urothelial Cancer TreatmentsFrench-language works237,207